← Signals · Healthcare · TSXV
$PAIN
Vector Science and Therapeutics Corp.
Signal as of N/A  ·  90-day rolling window  ·  Biotechnology & Life Sciences
Confluence Score
—
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 47% of the time (avg +6.8% over 90 days, 105 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
No insider transactions in window Lobbying: 0 regs  ·  Contracts: 0 wins
Confluence Score
—
Unlock breakdown →
Insider Activity (90d)
0
0 buyers  ·  —  ·  open-market only
Current Price
$2.32
CAD  ·  5-min cache
Market Cap
$362M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 43% hit rate · -5.4% alpha vs XIU.TO · 21 closed signals Track Record →
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:PAIN
Insider Transactions
90-day window  ·  5 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
May 29, 2026 Dobranowski, Alexander Julian — Comp. Grant Buy 68,870 — — —
May 29, 2026 Thompson, Tommy George — Comp. Grant Buy 68,870 — — —
May 29, 2026 Kelly, Scott — Comp. Grant Buy 68,870 $1.69 +37.3%  · 44d $116K
Apr 24, 2026 Dobranowski, Alexander Julian — Other Sell — — — —
Apr 24, 2026 Bachinski, Thomas Jerome — Other Sell — — — —
Score uses open-market buys only  ·  0 open-market  ·  3 plan / compensation shown but not scored  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 0 30 No insider activity
Buy/sell ratio 20 0% buys (0B / 0S)
Dollar value 25 No open-market buys
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 0 100
Unlock Component Detail — CAD $29/mo
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for PAIN.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Jun 30, 2026
Shares short
106,400
Net change
-32,134 (-23.2%)
History
Jun 30: 106,400
Jun 15: 138,534
May 31: 10,353
May 15: 7,031
Apr 30: 1,110
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.